Nordic real estate market is in trouble but might as well go down with the ship. Small dividend reinvestment with a purchase of 90 shares or Cibus Nordic Real Estate AB for 106,95 SEK per share. I wouldn’t be surprised if there’s still significant trouble ahead but let’s see. This is a small position and I have no intention to build larger one. Might do small additions but that’s about it.
Recent Buy: Fortum Oyj
Boring maintenance purchase but everything counts. Bought 20 shares of Fortum for 13,325 EUR per share. I still have slightly mixed feelings about Fortum but I might aim for a total position of 300 shares. If so, it will probably be a result of these small maintenance purchases.
Recent Swap: Telia Company AB to Nordea Bank Abp and Sampo Plc
Sold my small Telia Company position of 2000 shares for 2,356 EUR per share. Recorded a loss for taxes as I considered this to be too risky position without any dividend upside given the payout ratio and debt level. Should have sold long time ago but better late than never. Bought 167 shares of Nordea Bank for 10,432 EUR per share and 20 Sampo Plc shares for 44,99 EUR per share as initial replacement.
Recent Buy: Nordea Bank Abp
Small maintenance purchase or more like a dividend reinvestment with a purchase of 20 shares of Nordea bought for 9,75 EUR per share. Nothing special here as I see significant risks in the sector globally but consider Nordea strong enough to sail through the storm. Might still nibble additional shares but likely won’t do any major moves since exposure is already on the high side.
Recent Buy: Medtronic
Like planned, addition to recently opened Medtronic position with a purchase of 20 shares bought for 79,37 USD per share. Thesis is still in place: reasonable enough valuation, suitable sector and decent yield and dividend growth. Share price has trended down for quite some time and rightfully so, but in my opinion turning the trend slowly is likely enough. There are of course risks but in risk-reward terms I consider this package good enough. Main point is increasing the exposure to the medical sector which I will likely continue in coming months. Size of Medtronic position is still open but let’s see how valuations move. I would be inclined to add on Johnson & Johnson and Pfizer as well but intention is to only reinvest dollar dividends. Therefore ammunition is somewhat limited.
Q1/2023 Results
First quarter of the year is over. In many ways it was as turbulent and those before it. War in Ukraine is still going but US threw minor banking crisis in the mix to spice things up. This didn’t hit my portfolios too badly. Main portfolio dropped -3,54% during first quarter and dividend income during quarter was solid 2486,69 EUR before taxes (converted to EUR on April 1st). This included part of the dividends paid out by Nordea which were already registered on one account during March even though actual pay date is on April. Then again BHP dividends were not registered in time.
Rest of the year appears to be quite foggy. This banking crisis is looming but to me it doesn’t appear likely be a huge hit, at least if moral impact is not considered. War in Ukraine is likely to go on for a long time but Ukraine seems well positioned and I don’t see how Russia could walk out of this with anything that could be counted as victory even by Russian standards. Finland is having elections tomorrow and chances are that we will get new government to clear up the economical mess left behind. If everything goes well, Finland might also be a NATO member as early as next week. These two have potential to enable positive loop for us but start might be painful. It remains to be seen if this would lead into more sensible taxation environment. For now I’ll probably continue adding on stocks with moderate pace. In other words I’ll not maximise purchase but will let cash to gradually build up until better opportunities come up.
Recent Buy: Nordea Bank & Fortum
Things escalated quickly in the banking sector. Silicon Valley Bank collapsed and US regulators came up with emergency plan during the weekend. I was expecting a bit more turbulent opening today but ended up buying 100 shares of Nordea Bank for 11,08 EUR per share. Financial system – including European one – is far from solid but I consider it unlikely that Nordea would take significant hits in short term. Ex-dividend date is also quickly approaching so didn’t go for bigger purchases just yet but will have to see how these things unfold in the coming days and weeks.
While at it, I decided to buy additional 80 shares of Fortum for 14,1 EUR per share. Still have somewhat mixed feelings about the company and state ownership but most likely I’ll build a half position during the second quarter. Sector itself is kind of must have and Fortum is reasonably well positioned for the energy transition taking place in next 10-15 years. Sure, the Uniper fiasco and still pending exit from Russia still stings but perhaps it will help keeping some idle hands bound for the said time period. Just in case someone gets ideas about branching out and expanding.
Recent Buy: Kemira Oyj
This was a bit unplanned move but state owned Solidium decided to sell 8 million shares of Kemira. They got 16,20 EUR per share which translated to a discount of about 2 EUR per share. At the time it wasn’t clear who bought these but I decided to jump in and bought additional 90 shares for the said price of 16,20 EUR per share. I didn’t consider this to be exceptionally good price but still significant drop with potential for quick rebound. Since then it was published that about 1.5 million shares were bought by Oras Invest. This is good news as they are already significant shareholders and – as family type of affair – likely in it for the long haul. Without any additional surprises or special circumstances I consider this position now to be full.
Recent Buy: Fortum Oyj
Not totally happy how things have evolved with Fortum but made a small maintenance purchase and bought 20 shares for 14,565 EUR per share. It’s a bit unlikely that I would build a full position here but possibly half position. Biggest shareholder is my main problem here but then again company itself is likely relevant for next 10 to 15 years. Valuation is not exactly bargain but decent all things considered.
Recent Buy: Medtronic
Initiated a new position by buying 20 shares of Medtronic for 82,58 USD per share. This is likely a position I will build during the first half of the year depending of course how the stock moves. Thesis is very simple as stock has dropped significantly, it offers decent dividend yield and history. Company itself operates in segments which benefit from the state of general population and are therefore not likely to go out of fashion.